ConductScience.org, home

Trial · NCT03806452

Participant flow12

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Initial Treatment PeriodSTARTEDHydroxycarbamide46
Initial Treatment PeriodSTARTEDPlacebo40
Initial Treatment PeriodCOMPLETEDHydroxycarbamide44
Initial Treatment PeriodCOMPLETEDPlacebo38
Initial Treatment PeriodNOT COMPLETEDHydroxycarbamide2
Initial Treatment PeriodNOT COMPLETEDPlacebo2
Responders Extended Treatment PeriodSTARTEDHydroxycarbamide18
Responders Extended Treatment PeriodSTARTEDPlacebo15
Responders Extended Treatment PeriodCOMPLETEDHydroxycarbamide15
Responders Extended Treatment PeriodCOMPLETEDPlacebo9
Responders Extended Treatment PeriodNOT COMPLETEDHydroxycarbamide3
Responders Extended Treatment PeriodNOT COMPLETEDPlacebo6

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03806452/flow